HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Kiyohiro Ando Selected Research

Aftercare (After-Treatment)

1/2020High expression of olfactomedin-4 is correlated with chemoresistance and poor prognosis in pancreatic cancer.
9/2019Plasma Levels of Soluble PD-L1 Correlate With Tumor Regression in Patients With Lung and Gastric Cancer Treated With Immune Checkpoint Inhibitors.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Kiyohiro Ando Research Topics

Disease

16Neoplasms (Cancer)
05/2024 - 08/2004
11Neuroblastoma
05/2023 - 06/2004
5Carcinoma (Carcinomatosis)
05/2024 - 06/2004
4Pancreatic Neoplasms (Pancreatic Cancer)
01/2021 - 10/2017
3Urinary Bladder Neoplasms (Bladder Cancer)
05/2024 - 09/2019
2Carcinogenesis
01/2023 - 10/2019
2Stomach Neoplasms (Stomach Cancer)
02/2021 - 09/2019
1Pyruvate Kinase Deficiency of Red Cells
05/2023
1Neoplasm Metastasis (Metastasis)
03/2023
1Inflammation (Inflammations)
03/2023
1Parotid Neoplasms
02/2021
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
02/2021
1Melanoma (Melanoma, Malignant)
02/2021
1Ataxia Telangiectasia (Louis Bar Syndrome)
07/2019
1Lung Neoplasms (Lung Cancer)
11/2008
1Starvation
02/2008
1Osteosarcoma (Osteogenic Sarcoma)
02/2008
1Breast Neoplasms (Breast Cancer)
08/2006
1Hepatoblastoma
08/2004

Drug/Important Bio-Agent (IBA)

5Proteins (Proteins, Gene)FDA Link
05/2023 - 06/2004
5Messenger RNA (mRNA)IBA
02/2022 - 06/2004
4DNA (Deoxyribonucleic Acid)IBA
05/2023 - 11/2008
3pembrolizumabIBA
05/2024 - 02/2022
3Phosphotransferases (Kinase)IBA
01/2023 - 06/2004
2Immune Checkpoint InhibitorsIBA
10/2023 - 09/2019
2Small Interfering RNA (siRNA)IBA
04/2023 - 09/2008
2Cisplatin (Platino)FDA LinkGeneric
03/2023 - 06/2004
2Hemoglobins (Hemoglobin)IBA
03/2023 - 02/2022
2PF 00477736IBA
01/2020 - 07/2019
2ElementsIBA
12/2009 - 09/2008
2Glucose (Dextrose)FDA LinkGeneric
12/2009 - 02/2008
1Interferon-gamma (Interferon, gamma)IBA
05/2024
1PlatinumIBA
05/2024
1Platelet-Derived Growth FactorIBA
10/2023
1DNA Ligases (Ligases, DNA)IBA
05/2023
1olaparibIBA
04/2023
1Poly(ADP-ribose) Polymerase InhibitorsIBA
04/2023
1A-Form DNA (A-DNA)IBA
04/2023
1TropomyosinIBA
01/2023
1Nerve Growth Factor Receptors (Neurotrophin Receptors)IBA
01/2023
1Transcription Factors (Transcription Factor)IBA
01/2023
1Folic Acid (Vitamin M)FDA LinkGeneric
12/2022
1Fluorouracil (Carac)FDA LinkGeneric
12/2022
1UNC1999IBA
12/2022
1Thymidylate SynthaseIBA
12/2022
1AlbuminsIBA
02/2022
1Type 2 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 2)IBA
02/2022
1B7-H1 AntigenIBA
02/2021
1Polymeric Immunoglobulin Receptors (Polymeric Immunoglobulin Receptor)IBA
01/2020
1Protein Isoforms (Isoforms)IBA
10/2019
1Tretinoin (Retinoic Acid)FDA LinkGeneric
10/2019
1Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA
07/2019
1Biomarkers (Surrogate Marker)IBA
10/2017
1Cell-Free Nucleic AcidsIBA
10/2017
1AgarIBA
12/2013
1Carrier Proteins (Binding Protein)IBA
12/2009
1CarbonIBA
12/2009
1AMP-Activated Protein KinasesIBA
12/2009
1Immunoglobulins (Immunoglobulin)IBA
11/2008
1Cell Adhesion Molecule-1IBA
11/2008
1Doxorubicin (Adriamycin)FDA LinkGeneric
08/2006
1Indicators and Reagents (Reagents)IBA
08/2004
1alpha-Fetoproteins (alpha-Fetoprotein)IBA
08/2004
1beta CateninIBA
08/2004

Therapy/Procedure

7Therapeutics
05/2024 - 09/2019
2Drug Therapy (Chemotherapy)
03/2023 - 01/2020
2Aftercare (After-Treatment)
01/2020 - 09/2019
1Precision Medicine
01/2021